Clinical Trial Update: Endothelin-1 Receptor Blockade in Resistant Hypertension [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating endothelin-1 receptor blockade for resistant hypertension is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Resistant Hypertension

Drugs mentioned

• Endothelin-1 receptor blocker

Snippet

Sponsor: University Hospital, Rouen | Conditions: Resistant Hypertension | Phase 2 | Status: RECRUITING